Prometheus Laboratories, Inc. v. Mayo Collaborative Services

**What Happened:** This case involved a dispute between Prometheus Laboratories and Mayo Collaborative Services over a patent for medical testing methods. Prometheus had developed a way to measure drug levels in patients' blood to help doctors determine the right medication dosages. Mayo argued that this testing method was too basic to deserve patent protection, claiming it simply observed natural processes in the human body that anyone should be able to study and use. **What the Court Decided:** The Federal Circuit Court ruled in favor of Prometheus Laboratories. The court determined that the testing method was sophisticated enough to qualify for patent protection. They found that it involved more than just observing natural body processes - it required specific steps and analysis that made it a legitimate invention worthy of patent rights. **Why This Matters for Workers:** This decision affects workers in medical and laboratory settings by clarifying that certain diagnostic procedures can be owned by companies through patents. This means healthcare workers and lab technicians may need to use specific licensed methods or equipment when performing certain tests. It also impacts how medical companies develop and protect their testing innovations, potentially affecting job opportunities and training requirements in the healthcare industry.